PacBio Announces Second Quarter 2022 Financial Results

MENLO PARK, Calif., Aug. 3, 2022 /PRNewswire/ -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended June 30, 2022. Second quarter results Revenue of $35.5 million, a 16% increase compared with $30.6 million in the prior year period. Delivered 36 Sequel II/IIe...

Click to view original post